SUMMIT THERAPEUTICS Trademark

Trademark Overview


On Monday, April 8, 2024, a trademark application was filed for SUMMIT THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SUMMIT THERAPEUTICS trademark a serial number of 98489105. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, January 26, 2026. This trademark is owned by SUMMIT THERAPEUTICS SUB INC.. The SUMMIT THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of malignancies; pharmaceutical preparations, namely, antitumor agents; pharmaceutical preparations for use in humans for the treatment of cancer and immunological diseases; pharmaceutical preparations for the treatment of cancer and for use in oncology and immuno-oncology
summit therapeutics

General Information


Serial Number98489105
Word MarkSUMMIT THERAPEUTICS
Filing DateMonday, April 8, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, January 26, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2025

Trademark Statements


NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical preparations for use in the treatment of malignancies; pharmaceutical preparations, namely, antitumor agents; pharmaceutical preparations for use in humans for the treatment of cancer and immunological diseases; pharmaceutical preparations for the treatment of cancer and for use in oncology and immuno-oncology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSUMMIT THERAPEUTICS SUB INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
US

Party NameSUMMIT THERAPEUTICS SUB INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
US

Trademark Events


Event DateEvent Description
Monday, April 8, 2024NEW APPLICATION ENTERED
Friday, April 12, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, April 12, 2024TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, September 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 22, 2024ASSIGNED TO EXAMINER
Wednesday, October 23, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 23, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, October 23, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 23, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, October 23, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 1, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 7, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 7, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 4, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 7, 2025TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, August 27, 2025SOU TEAS EXTENSION RECEIVED
Friday, January 16, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 7, 2025DIVISIONAL REQUEST RECEIVED
Monday, January 26, 2026DIVISIONAL PROCESSING COMPLETE
Wednesday, August 27, 2025SOU EXTENSION 1 FILED
Monday, January 26, 2026SOU EXTENSION 1 GRANTED
Monday, January 26, 2026CORRECTED NOA E-MAILED
Monday, January 26, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED